[Results of the use of a new synthetic antihistaminic (HS 592) in ophthalmology].
D003231:Conjunctivitis / Q000188:drug therapy*; D004485:Eczema / Q000188:drug therapy; D004487:Edema / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D007637:Keratoconjunctivitis / Q000188:drug therapy; D011759:Pyrrolidines / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D011759:Pyrrolidines
Risultati sull'impiego in oculistica di un nuovo antistaminico di sintesi (HS 592)